SK Biopharmaceuticals Signs 71.6 Billion KRW Pharmaceutical Supply Contract
SK Biopharmaceuticals has entered into a pharmaceutical supply contract worth 71.6 billion KRW, representing 10.1% of its recent annual revenue.
How this call is verified
The ▲ Bullish call is auto-verified against the actual KOSPI price in ~15h.
Bar: KOSPI ±0.9% within 24h · every verdict lands on the public ledger
AI comment — why bullish
This contract represents a meaningful addition to SK Biopharmaceuticals' top line, amounting to 10.1% of its most recent annual revenue. By securing a deal worth over 71 billion KRW, the company demonstrates a tangible revenue stream that exceeds the threshold for a material event. The counterparty is identified as SK Life Science, Inc., suggesting an internal or strategic distribution channel that likely streamlines the supply chain process. While the disclosure does not specify the duration or the specific product involved, the scale of the transaction provides a clear boost to the company's financial profile for the current period. If subsequent disclosures clarify that this contract is recurring rather than a one-time shipment, the earnings outlook for the next fiscal year will improve significantly.
Market data
SK바이오팜 · 326030 · KOSPI →Previous-close data, updated T+1 · Source: Financial Services Commission of Korea via data.go.kr
Key takeaway
"SK Biopharmaceuticals Signs 71.6 Billion KRW Pharmaceutical Supply Contract" — BullBear's AI rates this story as a bullish (positive) signal for markets, with a market-impact score of 60 out of 100. That score reflects how strongly the story is likely to move Bitcoin, US equities, the dollar, and gold, and near-duplicate coverage of the same event is clustered so only the representative article is scored. Reported by 금융감독원 전자공시(DART) on September 14, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 42.0%.